Raya Saab, MD

In Lebanon, children with cancer face life-threatening gaps in receiving referrals to specialists and delayed diagnosis to oncology care.

Liliana Vásquez, MD, MSc

In Peru, where late detection of childhood cancer is triple that of high-income countries, nearly half of kids with cancer are diagnosed after their disease has advanced.

Lauren Byers, MD

Until now, patients with lung cancer, the leading cause of cancer-related deaths in the U.S, have had few avenues for personalized treatment beyond standard care. For more than 10 years, Dr. Byers, of the University of Texas MD Anderson Cancer Center, has worked to detect biomarkers.

Carly Flumer and Dr. Mark Lewis

WHAT YOU'LL HEAR IN THIS EPISODE:

•    Tips for navigating cancer care as an AYA patient 
•    The importance of health literacy in the oncology space
•    Why Dr. Lewis encourages patients to record their visits

Stephanie Markovina, MD, PhD

Targeting the tumor-protective effects of squamous cell carcinoma antigen (SCCA1) with emerging tools is helping doctors personalize care for patients with cervical cancer. High levels of SCCA1 are a predictor of poor prognosis in this patient population.

William Matsui, MD

Many patients with multiple myeloma and other blood cancers initially respond well to treatment, but, inevitably, most patients face relapse. Dr.